Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
<p>Human tuberculosis (TB) is caused by various members of the <em>Mycobacterium tuberculosis</em> (Mtb) complex. Differences in host response to infection have been reported, illustrative of a need to evaluate efficacy of novel vaccine candidates against multiple...
Main Authors: | Painter, H, Willcocks, S, Zelmer, A, Reljic, R, Tanner, R, Fletcher, H |
---|---|
格式: | Journal article |
语言: | English |
出版: |
Elsevier
2024
|
相似书籍
-
Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
由: Tanner, R, et al.
出版: (2021) -
Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
由: Painter, H, et al.
出版: (2020) -
Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
由: Hannah Painter, et al.
出版: (2020-02-01) -
The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
由: Brennan, M, et al.
出版: (2017) -
A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
由: Pepponi, I, et al.
出版: (2017)